[go: up one dir, main page]

FI955524L - Kiinteinä liuoksina olevia valmisteita - Google Patents

Kiinteinä liuoksina olevia valmisteita Download PDF

Info

Publication number
FI955524L
FI955524L FI955524A FI955524A FI955524L FI 955524 L FI955524 L FI 955524L FI 955524 A FI955524 A FI 955524A FI 955524 A FI955524 A FI 955524A FI 955524 L FI955524 L FI 955524L
Authority
FI
Finland
Prior art keywords
preparations
solid solutions
solutions
solid
Prior art date
Application number
FI955524A
Other languages
English (en)
Swedish (sv)
Other versions
FI955524A0 (fi
FI955524A7 (fi
Inventor
Sven Grabowski
Winfried Mueller
Joerg Rosenberg
Rudolf Binder
Axel Sanner
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of FI955524A0 publication Critical patent/FI955524A0/fi
Publication of FI955524A7 publication Critical patent/FI955524A7/fi
Publication of FI955524L publication Critical patent/FI955524L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cephalosporin Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI955524A 1993-05-18 1994-05-09 Kiinteinä liuoksina olevia valmisteita FI955524L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4316537A DE4316537A1 (de) 1993-05-18 1993-05-18 Zubereitungen in Form fester Lösungen
PCT/EP1994/001489 WO1994026267A1 (de) 1993-05-18 1994-05-09 Zubereitungen in form fester lösungen

Publications (3)

Publication Number Publication Date
FI955524A0 FI955524A0 (fi) 1995-11-16
FI955524A7 FI955524A7 (fi) 1995-11-16
FI955524L true FI955524L (fi) 1995-11-16

Family

ID=6488330

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955524A FI955524L (fi) 1993-05-18 1994-05-09 Kiinteinä liuoksina olevia valmisteita

Country Status (23)

Country Link
US (1) US5684040A (fi)
EP (1) EP0697867B1 (fi)
JP (1) JPH08510219A (fi)
KR (1) KR960702305A (fi)
CN (1) CN1123524A (fi)
AT (1) ATE209913T1 (fi)
AU (1) AU688328B2 (fi)
BR (1) BR9406414A (fi)
CA (1) CA2163255A1 (fi)
CZ (1) CZ300895A3 (fi)
DE (2) DE4316537A1 (fi)
DK (1) DK0697867T3 (fi)
ES (1) ES2169073T3 (fi)
FI (1) FI955524L (fi)
HR (1) HRP940305A2 (fi)
HU (1) HUT73657A (fi)
IL (1) IL109532A (fi)
NO (1) NO954660L (fi)
NZ (1) NZ267080A (fi)
PL (1) PL311698A1 (fi)
SI (1) SI9420035A (fi)
WO (1) WO1994026267A1 (fi)
ZA (1) ZA943368B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20040013736A1 (en) * 2000-09-25 2004-01-22 Tomio Nakano Process for producing medicinal solid dispersion
EP1399190B1 (en) * 2001-06-22 2010-09-08 Bend Research, Inc. Pharmaceutical compositions comprising low-solubility and acid-sensitive drugs and neutralized acidic polymers
JP2004534811A (ja) * 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク ポリマーと薬剤の集合体を含む医薬組成物
CA2450957A1 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions of dispersions of drugs and neutral polymers
WO2003034302A1 (en) * 2001-10-15 2003-04-24 Stark Co., Ltd. Content delivery server and content delivery system having the same
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
IL162870A0 (en) 2002-02-01 2005-11-20 Pfizer Prod Inc Controlled release pharmaceutical dosage forms of a cholesteryl estertransfer protein inhibitor
AU2003249474A1 (en) 2002-08-12 2004-02-25 Pfizer Products Inc. Pharmaceutical compositions of semi-ordered drugs and polymers
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
EP1650200A4 (en) * 2003-07-11 2008-03-19 Osaka Ind Promotion Org SULPHONATE COMPOUND AND FLUORESCENCE ENCODER USING THIS
WO2005005401A1 (ja) * 2003-07-11 2005-01-20 Osaka Industrial Promotion Organization スルホン酸エステル化合物およびそれを用いた蛍光プローブ
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS5446837A (en) * 1977-09-19 1979-04-13 Kanebo Ltd Easily absorbable nifedipin composition, its preparation, and anti-stenocardia containing the same
BE880713A (fr) * 1978-12-21 1980-06-19 Sandoz Sa Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
DE3243158A1 (de) * 1982-11-23 1984-05-24 Basf Ag, 6700 Ludwigshafen Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンa物質含有易溶性固形製剤
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
JP2636265B2 (ja) * 1987-10-06 1997-07-30 萬有製薬株式会社 脳循環改善剤
DE3830355A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur herstellung von pharmazeutischen tabletten
DE3834860A1 (de) * 1988-10-13 1990-04-19 Basf Ag Heterocyclisch substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Also Published As

Publication number Publication date
NO954660D0 (no) 1995-11-17
NZ267080A (en) 1996-11-26
CZ300895A3 (en) 1996-02-14
CA2163255A1 (en) 1994-11-24
HU9503296D0 (en) 1996-01-29
PL311698A1 (en) 1996-03-04
CN1123524A (zh) 1996-05-29
SI9420035A (en) 1996-06-30
FI955524A0 (fi) 1995-11-16
IL109532A (en) 1997-11-20
ZA943368B (en) 1995-11-17
ATE209913T1 (de) 2001-12-15
KR960702305A (ko) 1996-04-27
BR9406414A (pt) 1995-12-19
JPH08510219A (ja) 1996-10-29
EP0697867B1 (de) 2001-12-05
DK0697867T3 (da) 2002-03-11
HUT73657A (en) 1996-09-30
NO954660L (no) 1995-11-17
ES2169073T3 (es) 2002-07-01
WO1994026267A1 (de) 1994-11-24
DE59409994D1 (de) 2002-01-17
EP0697867A1 (de) 1996-02-28
IL109532A0 (en) 1994-08-26
FI955524A7 (fi) 1995-11-16
HRP940305A2 (en) 1996-12-31
US5684040A (en) 1997-11-04
DE4316537A1 (de) 1994-11-24
AU6926394A (en) 1994-12-12
AU688328B2 (en) 1998-03-12

Similar Documents

Publication Publication Date Title
FI933104L (fi) Foerfarande foer delignifiering av kemisk pappersmassa
DE69415340D1 (de) Kosmetisches präparat
ITMI940144A0 (it) Soluzioni e loro preparazione
FI944624A0 (fi) 4-aryyliaminobentsopyraani- ja niiden kaltaisia yhdisteitä
FI951330A0 (fi) Sihti
FI933103L (fi) Foerfarande foer blekning av kemisk pappersmassa
DE59407063D1 (de) Deodorierende zubereitungen
DE69328575D1 (de) Dermatologische Präparate
FI933105L (fi) Foerfarande foer delignifiering av kemisk pappersmassa
FI933201L (fi) Vaerme- och kylvals
FI955524A7 (fi) Kiinteinä liuoksina olevia valmisteita
DE69429514D1 (de) Antiparasitäre präparate
ITMI922776A1 (it) Soluzioni crioprotettrici
DE69413111D1 (de) Shampoozusammensetzung
DE59407311D1 (de) Leukoindigo-präparationen in granulatform
FI933019L (fi) Bensotiazepin- och bensoxatzepinderivat
FI911510A7 (fi) Hydroksimetyyli-indolitsidiinejä ja -kinolitsidiinejä
FI1031U1 (fi) En troakar
ITMI921571A1 (it) Azaciclo e azabiciclo alchiliden idrossilamine
DE69407922D1 (de) Supraleiter
FI1295U1 (fi) En baerande traekonstruktion
NO924816D0 (no) Retningsmaaling i broenn
DK103393D0 (da) Praeparat
KR950016500U (ko) 운동구겸용 침대
SE9203239D0 (sv) I l-list